Triple therapy in Rheumatoid Ahritis involves all except
Methotrexate is the DMARD of the first choice for initial treatment of moderate to severe RA. Failure to achieve adequate improvement with methotrexate therapy calls for a change in DMARD therapy, usually transition to an effective combination regimen. Effective combinations include methotrexate, sulfasalazine, and hydroxychloroquine (oral triple therapy); methotrexate and leflunomide; and methotrexate plus a biological.Reference: Harrison&;s Principles of Internal Medicine; 19th edition; Chapter 380; Rheumatoid ahritis
Methotrexate
Hydroxychloroquine
Steroids
Sulphasalazine
C.V.S